851 related articles for article (PubMed ID: 33516602)
1. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
Dal-Ré R
Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
[No Abstract] [Full Text] [Related]
2. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
Joffe S
JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
[No Abstract] [Full Text] [Related]
3. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.
Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1653-1656. PubMed ID: 33382675
[TBL] [Abstract][Full Text] [Related]
4. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
Dal-Ré R; Caplan AL; Gluud C; Porcher R
Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
[TBL] [Abstract][Full Text] [Related]
5. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization.
Khehra N; Padda I; Jaferi U; Atwal H; Narain S; Parmar MS
AAPS PharmSciTech; 2021 Jun; 22(5):172. PubMed ID: 34100150
[TBL] [Abstract][Full Text] [Related]
6. FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996
[No Abstract] [Full Text] [Related]
7. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
Kesselheim AS; Darrow JJ; Kulldorff M; Brown BL; Mitra-Majumdar M; Lee CC; Moneer O; Avorn J
Health Aff (Millwood); 2021 Jan; 40(1):25-32. PubMed ID: 33211535
[TBL] [Abstract][Full Text] [Related]
8. Vaccine safety - is the SARS-CoV-2 vaccine any different?
Tau N; Yahav D; Shepshelovich D
Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
[TBL] [Abstract][Full Text] [Related]
9. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
Krause PR; Gruber MF
N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383
[No Abstract] [Full Text] [Related]
10. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
Dal-Ré R; Orenstein W; Caplan AL
Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
[No Abstract] [Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
12. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA.
Pai SM; Othman AA; Rusch L; Masters JC; Greene D; Rogge M; Gries JM; Clementi W; Kumar P; Younis I; Salem AH; Gaynes BI; Pastino G; Derendorf H;
J Clin Pharmacol; 2021 Mar; 61(3):277-279. PubMed ID: 33274473
[No Abstract] [Full Text] [Related]
13. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
Thomson K; Nachlis H
JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
[No Abstract] [Full Text] [Related]
14. Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
Rizk JG; Forthal DN; Kalantar-Zadeh K; Mehra MR; Lavie CJ; Rizk Y; Pfeiffer JP; Lewin JC
Drug Discov Today; 2021 Feb; 26(2):593-603. PubMed ID: 33253920
[TBL] [Abstract][Full Text] [Related]
15. The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
Singh JA; Upshur REG
Lancet Infect Dis; 2021 Apr; 21(4):e103-e109. PubMed ID: 33306980
[TBL] [Abstract][Full Text] [Related]
16. FDA authorizes Johnson & Johnson COVID-19 vaccine.
Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088
[No Abstract] [Full Text] [Related]
17. FDA authorizes first single-shot COVID-19 vaccine.
Mullard A
Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
[No Abstract] [Full Text] [Related]
18. A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
Follmann D; Fintzi J; Fay MP; Janes HE; Baden LR; El Sahly HM; Fleming TR; Mehrotra DV; Carpp LN; Juraska M; Benkeser D; Donnell D; Fong Y; Han S; Hirsch I; Huang Y; Huang Y; Hyrien O; Luedtke A; Carone M; Nason M; Vandebosch A; Zhou H; Cho I; Gabriel E; Kublin JG; Cohen MS; Corey L; Gilbert PB; Neuzil KM
Ann Intern Med; 2021 Aug; 174(8):1118-1125. PubMed ID: 33844575
[TBL] [Abstract][Full Text] [Related]
19. Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.
Powell J; Piszczatoski CR
Ann Pharmacother; 2022 Sep; 56(9):1058-1064. PubMed ID: 35012364
[TBL] [Abstract][Full Text] [Related]
20. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
Milane L; Amiji M
Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
